Ovid Therapeutics (OVID) Market Capitalization (2017 - 2026)

Ovid Therapeutics (OVID) has reported Market Capitalization for 10 consecutive years, with $497.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 2017.92% year-over-year to $497.0 million; the trailing twelve-month figure through Jun 2026 stood at $497.0 million (up 2017.92% YoY), and the FY2025 full-year result was $120.2 million, up 82.0% from the prior year.
• Market Capitalization grew to $497.0 million in Q2 2026 per OVID's latest filing, from $302.3 million in the prior quarter.
• Across five years, Market Capitalization topped out at $497.0 million in Q2 2026 and bottomed at $22.0 million in Q1 2025.
• Historically, Market Capitalization has averaged $168.0 million across 5 years, with a median of $141.2 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization sank 89.79% in 2025, then soared 2017.92% in 2026.
• Over 5 years, Market Capitalization stood at $131.1 million in 2022, then soared by 73.67% to $227.6 million in 2023, then slumped by 70.99% to $66.0 million in 2024, then jumped by 82.0% to $120.2 million in 2025, then surged by 313.5% to $497.0 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $497.0 million, $302.3 million, and $120.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.